» Articles » PMID: 29215618

Is Double-Dose Esomeprazole With Bismuth Really Safe?

Overview
Specialty Gastroenterology
Date 2017 Dec 8
PMID 29215618
Authors
Affiliations
Soon will be listed here.
References
1.
Megraud F . The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy. Therap Adv Gastroenterol. 2012; 5(2):103-9. PMC: 3296089. DOI: 10.1177/1756283X11432492. View

2.
Scarpignato C, Gatta L, Zullo A, Blandizzi C . Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression. BMC Med. 2016; 14(1):179. PMC: 5101793. DOI: 10.1186/s12916-016-0718-z. View

3.
Shaikh A, Giridhar R, Megraud F, Yadav M . Metalloantibiotics: synthesis, characterization and antimicrobial evaluation of bismuth-fluoroquinolone complexes against Helicobacter pylori. Acta Pharm. 2009; 59(3):259-71. DOI: 10.2478/v10007-009-0027-6. View

4.
Phillips R, Whitehead M, Doig L, Sieniawska C, Delves H, Thompson R . Is eradication of Helicobacter pylori with colloidal bismuth subcitrate quadruple therapy safe?. Helicobacter. 2001; 6(2):151-6. DOI: 10.1046/j.1523-5378.2001.00022.x. View

5.
Hsu P, Tsai F, Kao S, Hsu W, Cheng J, Peng N . Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled.... Am J Gastroenterol. 2017; 112(9):1374-1381. DOI: 10.1038/ajg.2017.195. View